The metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), also known as nuclear-enriched abundant transcript 2 (NEAT2), was firstly identified in 2003 by subtractive hybridization as prognostic parameters for patient survival in stage I of NSCLC. Here, MALAT1 is linked to non-small cell lung carcinoma.